Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Drugs|January 1, 1986
Aldose reductase inhibitors in clinical practice. Preliminary studies on diabetic neuropathy and retinopathyN E Pitts, K Gundersen, D J Mehta, et al.
Metabolism: Clinical and Experimental|April 1, 1986
Clinical experience with sorbinil--an aldose reductase inhibitorN E Pitts, F Vreeland, G L Shaw, et al.
Lung Cancer (Amsterdam, Netherlands)|May 1, 1997
Frequency of the variant allele CYP2D6(C) among North American Caucasian lung cancer patients and controlsG L Shaw, B Weiffenbach, R T Falk, et al.
Human Molecular Genetics|June 1, 1994
Identification of a new variant CYP2D6 allele with a single base deletion in exon 3 and its association with the poor metabolizer phenotypeR Saxena, G L Shaw, M V Relling, et al.
Structure (London, England : 1993)|July 15, 1994
The solution structure and dynamics of the DNA-binding domain of HMG-D from Drosophila melanogasterD N Jones, M A Searles, G L Shaw, et al.
Biological Cybernetics|March 17, 2001
Reliable short-term memory in the trion model: toward a cortical language and grammarM Sardesai, C Figge, M Bodner, et al.
Cancer Causes & Control : CCC|May 1, 1993
Race and sex differences in associations of vegetables, fruits, and carotenoids with lung cancer risk in New Jersey (United States)J F Dorgan, R G Ziegler, J B Schoenberg, et al.
Environmental Health Perspectives|November 1, 1992
The debrisoquine metabolic phenotype and DNA-based assays: implications of misclassification for the association of lung cancer and the debrisoquine metabolic phenotypeN E Caporaso, P G Shields, M T Landi, et al.
Cancer|August 1, 1993
Scientific basis for cancer prevention. Intermediate cancer markersJ L Mulshine, M Jett, F Cuttitta, et al.
Lung Cancer (Amsterdam, Netherlands)|March 1, 1994
Integrated clinical and basic studies related to circumventing non-small cell lung cancer drug resistanceJ L Mulshine, B E Johnson, A F Gazdar, et al.
Pageof 6